Scholar Rock Holding Corp - Srk-181 Combination With Pembrolizumab Was Generally Well Tolerated
Scholar Rock控股公司 - SRK-181與Pembrolizumab的聯合使用通常耐受良好
Scholar Rock Holding Corp - Srk-181 Combination With Pembrolizumab Was Generally Well Tolerated
Scholar Rock控股公司 - SRK-181與Pembrolizumab的聯合使用通常耐受良好
譯文內容由第三人軟體翻譯。